# Bain Capital Specialty Finance, Inc.: overview

BCSF · NYSE · CIK 1655050 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcsf.md) · [Financials](/companies/bcsf/financials.md) · [Filings](/companies/bcsf/filings.md) · [Insiders](/companies/bcsf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.51](/filings/0001193125-26-077703.md) | [0.34](/filings/0001193125-26-077703.md) | [0.44](/filings/0001193125-26-217068.md) | [0.37](/filings/0001193125-26-342491.md) | [0.29](/filings/0001193125-26-077703.md) | [0.43](/filings/0001193125-26-077703.md) | [0.05](/filings/0001193125-26-217068.md) | [0.22](/filings/0001193125-26-342491.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.86](/filings/0000950170-24-021337.md) | [1.63](/filings/0000950170-25-029152.md) | [1.91](/filings/0001193125-26-077703.md) | [1.85](/filings/0001193125-26-077703.md) | [1.53](/filings/0001193125-26-077703.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcsf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Bain Capital Credit, LP](/funds/1317947.md) | 2026-06-30 | $148.0m | 11,822,433 |  | Unchanged |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $31.8m | 2,540,286 |  | Reduced −197,189 |
| [Cresset Asset Management, LLC](/funds/1761013.md) | 2026-06-30 | $30.0m | 2,394,561 |  | Added +321,717 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $18.3m | 1,460,135 |  | Added +55,587 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $17.3m | 1,378,326 |  | Added +253,902 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $17.2m | 1,374,383 |  | Reduced −140,572 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15.7m | 1,254,889 |  | Added +108,756 |
| [DIMENSION CAPITAL MANAGEMENT LLC](/funds/1041773.md) | 2026-06-30 | $15.7m | 1,253,662 |  | Added +29,172 |
| [Melia Wealth LLC](/funds/1964047.md) | 2026-06-30 | $10.9m | 872,753 |  | Reduced −290,335 |
| [Muzinich & Co., Inc.](/funds/1618824.md) | 2026-06-30 | $10.6m | 846,759 |  | Added +45,502 |

## Recent filings

[All 452 filings](/companies/bcsf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 16:57 ET | [8-K](/filings/0001193125-26-342607.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342607 |
| 2026-08-10 | 16:33 ET | [10-Q](/filings/0001193125-26-342491.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342491 |
| 2026-07-31 | 20:11 ET | [8-K](/filings/0001193125-26-326509.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-326509 |
| 2026-07-23 | 16:05 ET | [8-K](/filings/0001193125-26-314080.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-314080 |
| 2026-05-22 | 11:27 ET | [8-K](/filings/0001193125-26-235868.md) | 5.07 Shareholder vote results | 0001193125-26-235868 |
| 2026-05-12 | 18:02 ET | [8-K](/filings/0001193125-26-217311.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-217311 |
| 2026-05-11 | 17:03 ET | [10-Q](/filings/0001193125-26-217068.md) | Quarterly report, period 2026-03-31 | 0001193125-26-217068 |
| 2026-04-29 | 08:00 ET | [8-K](/filings/0001193125-26-189075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-189075 |
| 2026-04-20 | 16:11 ET | [DEF 14A](/filings/0001193125-26-163964.md) | Proxy statement, period 2026-05-21 | 0001193125-26-163964 |
| 2026-02-27 | 21:35 ET | [8-K](/filings/0001193125-26-078696.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-078696 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-077703.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1655050
- Tickers: BCSF
- Exchange: NYSE
- SIC code: not reported
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.